Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inactivation of ApoC3 by CRISPR/Cas9 Protects Against Atherosclerosis in Hamsters.

× No keyword cloud information.

6 in total

1. Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis.

Authors: Xunde Xian; Yuhui Wang; George Liu
Journal: Methods Mol Biol Date: 2022

Review 2. Gene editing and its applications in biomedicine.

Authors: Guanglei Li; Xiangyang Li; Songkuan Zhuang; Liren Wang; Yifan Zhu; Yangcan Chen; Wen Sun; Zeguang Wu; Zhuo Zhou; Jia Chen; Xingxu Huang; Jin Wang; Dali Li; Wei Li; Haoyi Wang; Wensheng Wei
Journal: Sci China Life Sci Date: 2022-02-18 Impact factor: 10.372

3. Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia.

Authors: Yitong Xu; Jiabao Guo; Ling Zhang; Guolin Miao; Pingping Lai; Wenxi Zhang; Lili Liu; Xinlin Hou; Yuhui Wang; Wei Huang; George Liu; Mingming Gao; Xunde Xian
Journal: Front Cardiovasc Med Date: 2022-02-02

4. CRISPR/Cas9-mediated knockout of APOC3 stabilizes plasma lipids and inhibits atherosclerosis in rabbits.

Authors: Yiwen Zha; Yaoyao Lu; Ting Zhang; Kunning Yan; Wenwen Zhuang; Jingyan Liang; Yong Cheng; Yingge Wang
Journal: Lipids Health Dis Date: 2021-12-18 Impact factor: 3.876

5. CRISPR/Cas9 based blockade of IL-10 signaling impairs lipid and tissue homeostasis to accelerate atherosclerosis.

Authors: Haozhe Shi; Jiabao Guo; Qiongyang Yu; Xinlin Hou; Lili Liu; Mingming Gao; Lili Wei; Ling Zhang; Wei Huang; Yuhui Wang; George Liu; Peter Tontonoz; Xunde Xian
Journal: Front Immunol Date: 2022-08-30 Impact factor: 8.786

Review 6. CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities.

Authors: Harry E Walker; Manfredi Rizzo; Zlatko Fras; Borut Jug; Maciej Banach; Peter E Penson
Journal: Metabolites Date: 2021-12-09

6 in total